Clinical significance of mucosal suppressors of cytokine signaling 3 expression in ulcerative colitis

doi:10.3748/wjg.v13.i21.2939

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3722)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

440

HTML

2845

Figures (1-7)

236

Tables (1-2)

201

Sum=3722

Jun 7, 2007 (publication date) through Nov 20, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Jun 7, 2007; 13(21): 2939-2944
Published online Jun 7, 2007. doi: 10.3748/wjg.v13.i21.2939

Full Size Figure Download Figure

Figure 7 Kaplan-Meier time to relapse curves for patients with UC in relation to the expression of SOCS mRNAs. There is a significant difference (P < 0.05, log rank) in the proportion of patients who relapsed over a 12-mo period with respect to the levels of mucosal SOCS3 (> or < 0.3) at time of inclusion in the study. There was no correlation between SOCS1 and remission rate. NS: not significant.

Citation: Miyanaka Y, Ueno Y, Tanaka S, Yoshioka K, Hatakeyama T, Shimamoto M, Sumii M, Chayama K. Clinical significance of mucosal suppressors of cytokine signaling 3 expression in ulcerative colitis. World J Gastroenterol 2007; 13(21): 2939-2944
URL: https://www.wjgnet.com/1007-9327/full/v13/i21/2939.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i21.2939